vTv Therapeutics Inc. (NASDAQ:VTVT) initiated its Phase 2 clinical trial for evaluating azeliragon in patients with mild Alzheimer’s disease and Type 2 Diabetes.
vTv
Therapeutics Inc. (NASDAQ:VTVT), a Healthcare sector firm, traded 226171 shares
in last trading session with closing price of $1.42 per share. Company return
on investment (ROI) is 29.80%. Stock value has moved between $0.68 – 6.17 in
last one year. Analyst’s mean target price for vTv Therapeutics Inc.
(NASDAQ:VTVT) is $6.50 while analysts mean recommendation is 2.00. VTVT EPS
growth this year is 34.60%.
Progress Software Corporation (NASDAQ:PRGS) came out with quarterly earnings of
$0.65 per share, beating the Zacks Consensus Estimate of $0.59 per share. This
compares to earnings of $0.60 per share a year ago. This quarterly report
represents an earnings surprise of 10.17%. A quarter ago, it was expected that
this business software maker would post earnings of $0.51 per share when it
actually produced earnings of $0.50, delivering a surprise of -1.96%.
On
last trading day, Progress Software Corporation (NASDAQ:PRGS) shares closed at
$40.63 per share. PRGS market capitalization is 1888.48 with beta of 0.73.
Analyst’s mean target price for Progress Software Corporation (NASDAQ:PRGS) is
$46.00. Its weekly performance is -4.17% while year to date (YTD) performance
is 14.48%.
The Goldman Sachs Group, Inc. (NYSE:GS) reported a $7.8 billion buyback plan
and raised its quarterly dividend from $0.85 to $1.25 per share.
In
last session The Goldman Sachs Group, Inc. (NYSE:GS) traded 2.17 Million shares
and was closed at $199.32. Analyst’s mean target price for GS is $230.76 while
analysts mean recommendation is 2.50. Company is -18.67% away from its 52 week
high and is moving 31.39% ahead of its 52 week low. GS Gross Margin is 62.20%
and its return on assets is 1.00%. The Goldman Sachs Group, Inc. (NYSE:GS)
quarterly performance is 4.26% while its price to sale ratio is 1.37.
The Bank of New York Mellon Corporation (NYSE:BK) announced a $3.94 billion
buyback and an increase in quarterly dividend from $0.28 to $0.31 per share.
The Bank of New York Mellon Corporation (NYSE:BK), a
Financial sector firm, traded 3.02 Million shares on last trading day with
closing price of $43.39 per share. Company return on investment (ROI) is 3.90%.
Stock value has moved between $42.13 – 55.63 in last one year. Analyst’s mean
target price for The Bank of New York Mellon Corporation (NYSE:BK) is $49.97
while analysts mean recommendation is 3.00. BK EPS growth this year is 29.50%.
